GENE ONLINE|News &
Opinion
Blog

Feature
Novavax’s COVID-19 Vaccine is Safe and Immunogenic in Early Trial
2020-08-06
Spotlight: New Gene Therapies on the Horizon for the Treatment of Neurogenetic Diseases
2020-08-03
CRISPR C-to-G Base Editors: A Therapeutic Promise
2020-07-31
COVID-19: Immunic, Inc. Begins Phase 2 Trial of IMU-838 in fusion with Oseltamivir
2020-07-30
Building a Biomedical Value Chain and Accelerating the Development of the Biomedical Industry
2020-07-29Partner
COVID-19 Vaccine: Moderna Begins Phase 3 COVE Study of mRNA-1273
2020-07-27
The Rise of Asia as a Destination of Biotech Investment and Opportunity
2020-07-27Partner
Innovative Diagnostics, AI, Blockchain and Telemedicine Boosts COVID-19 Fight
2020-07-26Partner
Efforts Behind the Taiwan Model of Combating COVID-19 Pandemic
2020-07-26Partner
A New Paradigm in Biotech Innovation and Investment
2020-07-24Partner
Part I Highlights of BIO Asia-Taiwan 2020 (Day 1): The Effect of COVID-19 on Global Biotech Industry
2020-07-22Partner
The Profound Impact of Duplex Sequencing: An Interview with Jesse Salk, CEO, TwinStrand Biosciences
2020-07-20
COVID-19: AstraZeneca and University of Oxford’s Vaccine Candidate Shows Promise in Early Human Trials
2020-07-20
COVID-19: Medicago Begins Phase I Trials for Plant-Based VLP Vaccine
2020-07-19
Pfizer & BioNTech’s COVID-19 Vaccine Receives FDA’s Fast Track Designation
2020-07-15
1 48 49 50 51 52 60
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top